Case presented by Dr Schwartz

Slides:

Advertisements

Similar presentations

Hepatic mass Yekaterina Rabkin 7/22/05.

Advertisements

AJCC Staging Moments AJCC TNM Staging 7th Edition Rectal Case #3 Contributors: J. Milburn Jessup, MD Cancer Diagnosis Program, DCTD, NCI, Rockville, Maryland.

Lower Gastrointestinal NET Clinical case One patient and how many doctors ? Dimitrios Dimitroulopoulos MD, PhD Consultant Gastroenterology Dpt. “Agios.

Tumor Markers Useful tool or part of the problem? Dr. Grant MacLean.

MOSAIC Stage ll+lll FOLFOX4 LV5FU2 Randomize. DFS DFS (months) Hazard ratio: 0.77 [0.65 – 0.92] p < 0.01 FOLFOX (n=1123) 77.9% LV5FU2 (n=1123) 72.8% FOLFOX.

A Phase III Trial Comparing FULV to FULV + Oxaliplatin in Stage II or III Carcinoma of the Colon: Results of NSABP-C-07 Norman Wolmark, MD Colorectal Cancer.

« A Clear cell sarcoma » FN. 25 year-old male January cm mass on the medial side of the right heel Early August cm clinical right.

Cervical Cancer Keith Unger 2/24/06. Clinical History 47 yo F with vaginal bleeding and pelvic pain On exam, large cervical mass with parametrial involvement.

Alexander Stein University Cancer Center Hamburg, Germany

Colorectal cancer Khayal AlKhayal MD,FRCSC

Post G.I. ASCO Update: Colorectal Cancer Ronald Burkes, M.D.

AJCC Staging Moments AJCC TNM Staging 7th Edition Colon Case #2 Contributors: J. Milburn Jessup, MD Cancer Diagnosis Program, DCTD, NCI, Rockville, Maryland.

Driving the Transition to Individualized Cancer Treatment by Addressing Critical Questions 1 Do I need surgery? chemotherapy? radiation? INVASIVE BREAST.

Colon Cancer Daniel A. Nikcevich, MD, PhD Duluth Clinic Cancer Center January 26, 2009.

N ational S urgical A djuvant B reast and B owel P roject.

Copyright © 2011 Research To Practice. All rights reserved. Case presented by Dr Morganstein (Prof Van Cutsem) 78 yo woman with Stage IV GE adenocarcinoma.

ΝΕΤ MasterClass 2015 ΙΩΑΝΝΗΣ ΠΙΛΠΙΛΙΔΗΣ, MD, FEBGH

Copyright © 2011 Research To Practice. All rights reserved. Case presented by Dr Schwartz 44 yo woman with 4 mo hx of abdominal pain –Imaging = pancreatic.

COLON CANCER A MAJOR ISSUE IN ALASKA. A common malignancy 200,000 cases in the U. S. in ,000 cases in the U. S. in 2008 Greater than 50 new cases.

Targeting HER2 and Focusing on Patients With Gastric Cancer Jose Maria Vieitez, MD, PhD Assistant Professor of Oncology Department of Medical Oncology.

By Dr. D. Narinesingh and team Presented by Nazreen Bhim.

Copyright © 2011 Research To Practice. All rights reserved. Faculty National GI Tumor Board Clinical Investigators Provide Their Perspectives on Current.

PSA Testing Importance of Multiple Markers Ian Thompson MD Department of Urology University of Texas HSC San Antonio, TX.

SWISS TUMOR BOARD Lung Cancer March 26, 2009 Novotel Bern Prof. Dr. Mahmut Ozsahin Lausanne University Medical Center (CHUV), Lausanne.

Copyright © 2011 Research To Practice. All rights reserved. Faculty National GI Tumor Board Clinical Investigators Provide Their Perspectives on Current.

UofT GU Oncology, 2004 CLINICAL CASES. UofT GU Oncology, y.o. female  Familiar history: Thyroid cancer (mother) Prostate cancer (father)  PMH:

Taiwan 2000 Is UGT1A1*28 homozygosity the strongest predictor for severe hematotoxicity in patients treated with 5- fluorouracil (5-FU)-irinotecan (IRI)?

0 Adjuvant FOLFIRI +/- Cetuximab in Patients with Resected Stage III Colon Cancer NCCTG Intergroup Phase III Trial N0147 Jocelin Huang, Daniel J Sargent,

EORTC Tumor response to pre-operative chemotherapy (CT) with FOLFOX-4 for resectable colorectal cancer liver metastases (LM) Interim results of the EORTC.

MRI IN PROSTATE CANCER MAHYAR GHAFOORI M.D. Associate Professor of Radiology Tehran University Of Medical Sciences.

Adjuvant Therapy of Colon Cancer: Where are we now ? Leonard Saltz, MD Memorial Sloan Kettering Cancer Center New York, NY.

Patterns of Care in Medical Oncology Treatment of Metastatic Colon Cancer.

Pancreatic Tumors in Children Presented by Damien W. Carter, MD.

Copyright © 2011 Research To Practice. All rights reserved. Faculty National GI Tumor Board Clinical Investigators Provide Their Perspectives on Current.

MGR - case R2. 유정선 / Prof. 정재헌. Case 송 O 섭 M/67 Adm date: Chief complaint Left neck mass o/s) 15 일전 Present illness 67/M, 2009.

POLYPS CHOLORECTAL CANCER M. DuBois Fennal, PhD, RN, CNS.

Phase III Clinical Trial of FOLFOX with or without Cetuximab in Resected Stage 3 Colon Cancer: Cooperative Group Trial N0147 (NCCTG*,

Case report Ovarian cancer Ami Fishman, M.D. Meir Hospital - Sapir Med Center Kfar-Saba, Israel Ovarian cancer Ami Fishman, M.D. Meir Hospital.

Special Seminar Series

A rare case of acute abdomen secondary to rupture of a Krukenberg tumor with intra- abdominal hemorrhage 三軍總醫院外科部大腸直腸外科浦大維糠榮誠 1.

Metastatic Amelanotic Melanoma

Diagnosis and Management Pearls

CCO Independent Conference Highlights

Case presented by Dr Polkinghorn

Treatment of Oligometatic PNET Mets to Liver Following Resection

Bladder Cancer and Prostatic Cancer

Current Patterns of Care in Breast Cancer: Use of Adjuvant Trastuzumab

Rosell R et al. Proc ASCO 2011;Abstract 7503.

A rare case of acute abdomen secondary to rupture of a Krukenberg tumor with intra- abdominal hemorrhage 三軍總醫院外科部大腸直腸外科報告人：浦大維 1.

Colorectal Cancer Update Patient Perspectives on Colorectal Cancer

National GI Tumor Board Clinical Investigators Provide Their Perspectives on Current Cases of Gastrointestinal Cancer Friday, January 21, :00.

BRAF mutant mCRC patients – What would you recommend? FOLFIRINOX/Bev

Case presented by Dr Moriarty

55-Year-Old Man With Anemia and Hemorrhagic Ascites

Pathway Targeted Immunotherapy: Rationale and Evidence of Durable Clinical Responses with a Novel, EGF-directed Agent for Advanced NSCLC Rafael Rosell,

National GI Tumor Board Clinical Investigators Provide Their Perspectives on Current Cases of Gastrointestinal Cancer Friday, January 21, :00.

What is the role of genetic testing in patients with ovarian cancer?

National GI Tumor Board Clinical Investigators Provide Their Perspectives on Current Cases of Gastrointestinal Cancer Friday, January 21, :00.

Renal Cell Carcinoma Associated With Sarcoidlike Tissue Reaction

Eung Chang Lee, Sung-Sik Han, Hyeong Min Park,

Steven Z. Pantilat, MD, Kathleen M. Kerr, BA, J

KRAS status and efficacy in the first-line treatment of patients with metastatic colorectal cancer treated with FOLFIRI with or without cetuximab: The.

22- Year-Old Man With Abdominal Pain and Rash

70-Year-Old Man With Abdominal Pain and Weight Loss

Altered Bowel Function

Colorectal Cancer in Older Patients Key Issues

General strategies of Cancer Treatment and evaluation of Response

Presentation transcript:

Case presented by Dr Schwartz 77 yo man: PMH – multiple medical problems 2003: L hemicolectomy stage III colon CA  6 mos adjuvant 5-FU/LV 8/2007: orchiectomy for DLBCL  R-CVP x 8 (h/o valvular heart ds), persistent tx-induced neuropathy 8/2009: NED 2010: abdominal pain  CEA >1200  PET/CT = liver lesions and 6.8 cm RP mass (? etiology) Biopsy x 2 = met colon CA

Case continued: 10/2010: FOLFIRI but enteritis and GI bleed post cycle 2 despite dose reduction 11/2010: Kras status identified from liver bx = wt Irinotecan/cetuximab with manageable rash and diarrhea CEA falling  rescan pending

Case presented by Dr Schwartz 77 yo man: PMH – multiple medical problems 2003: L hemicolectomy stage III colon CA  6 mos adjuvant 5-FU/LV 8/2007: orchiectomy for DLBCL  R-CVP x 8 (h/o valvular heart ds), persistent tx-induced neuropathy 8/2009: NED 2010: abdominal pain  CEA >1200  PET/CT = liver lesions and 6.8 cm RP mass (? etiology) Biopsy x 2 = met colon CA

Case continued: 10/2010: FOLFIRI but enteritis and GI bleed post cycle 2 despite dose reduction 11/2010: Kras status identified from liver bx = wt Irinotecan/cetuximab with manageable rash and diarrhea CEA falling  rescan pending

Case presented by Dr Schwartz 77 yo man: PMH – multiple medical problems 2003: L hemicolectomy stage III colon CA  6 mos adjuvant 5-FU/LV 8/2007: orchiectomy for DLBCL  R-CVP x 8 (h/o valvular heart ds), persistent tx-induced neuropathy 8/2009: NED 2010: abdominal pain  CEA >1200  PET/CT = liver lesions and 6.8 cm RP mass (? etiology) Biopsy x 2 = met colon CA

Case continued: 10/2010: FOLFIRI but enteritis and GI bleed post cycle 2 despite dose reduction 11/2010: Kras status identified from liver bx = wt Irinotecan/cetuximab with manageable rash and diarrhea CEA falling  rescan pending

National GI Tumor Board Clinical Investigators Provide Their Perspectives on Current Cases of Gastrointestinal Cancer Friday, January 21, 2011 7:00 PM – 9:30 PM San Francisco, California Moderator Neil Love, MD Faculty Charles D Blanke, MD David Cunningham, MD Steven A Curley, MD Eileen M O’Reilly, MD Eric Van Cutsem, MD, PhD Andrew X Zhu, MD, PhD 7 7